Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?

Eitemau Tebyg

• Baseline Ex Vivo and Molecular Responses of Plasmodium falciparum Isolates to Piperaquine before Implementation of Dihydroartemisinin-Piperaquine in Senegal
  gan: Robert, Marie Gladys, et al.
  Cyhoeddwyd: (2019)
• Prevalence of mutations in the Plasmodium falciparum chloroquine resistance transporter, PfCRT, and association with ex vivo susceptibility to common anti-malarial drugs against African Plasmodium falciparum isolates
  gan: Foguim, Francis Tsombeng, et al.
  Cyhoeddwyd: (2020)
• Absence of a High Level of Duplication of the Plasmepsin II Gene in Africa
  gan: Robert, Marie Gladys, et al.
  Cyhoeddwyd: (2018)
• Absence of Association between Methylene Blue Reduced Susceptibility and Polymorphisms in 12 Genes Involved in Antimalarial Drug Resistance in African Plasmodium falciparum
  gan: Gendrot, Mathieu, et al.
  Cyhoeddwyd: (2021)
• The D113N mutation in the RING E3 ubiquitin protein ligase gene is not associated with ex vivo susceptibility to common anti-malarial drugs in African Plasmodium falciparum isolates
  gan: Gendrot, Mathieu, et al.
  Cyhoeddwyd: (2018)